Drug Approval | November 17, 2021
Alembic JV receives final approval for Mupirocin cream
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
The drug helps in managing cholesterol
In India, MSD has signed non-exclusive licensing agreements with eight pharma companies.
This unique record was made possible by collating hard copies of the books in a structured manner
Dupixent is the only biologic medicine to improve lung function in children aged 6 to 11 years in a randomized Phase 3 trial, supporting potential as a best-in-class option
The drug is being developed at lab scale for the first-line of treatment of Covid-19
If authorized, molnupiravir could be the first oral antiviral medicine for the treatment of Covid-19
Subscribe To Our Newsletter & Stay Updated
